People · Operator
Named in public records as an officer, director or promoter · active 2017–2022 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Deepcell, Inc. | — | Biotechnology | Series C | $96.9M | $1.7B | 2019 |
| SlipChip Corp | — | Other Health Care | Series B | $59.5M | $641.2M | 2017 |
Matt Posard at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt Posard on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Mauney | 1 | 10 |
| Randy Scott | 1 | 5 |
| Felix Baker | 1 | 4 |
| Euan Ashley | 1 | 2 |
| Mahdokht Masaeli | 1 | 1 |
| Mahyar Salek | 1 | 1 |
| Brian Coe | 1 | 1 |
| Rustem Ismagilov | 1 | 1 |
| Blake Goodner | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.